X0306 4 2020-08-16 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001742587 Sinha Uma C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 Chief Scientific Officer Common Stock 2020-08-16 4 M 0 468 A 15991 D Restricted Stock Units 2020-08-16 4 M 0 468 0.00 D Common Stock 468 7032 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. 6.25% of the RSUs vested on August 16, 2020 and an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. /s/ Tara Condon, Attorney-in-Fact 2020-08-18